Bio-Rad Laboratories, Inc. (BIO)
USD 243.57
(4.85%)
USD 243.57
(4.85%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.18 Billion USD | -0.69% |
| 2022 | 1.19 Billion USD | 11291.63% |
| 2021 | 10.51 Million USD | -14.23% |
| 2020 | 12.25 Million USD | -9.73% |
| 2019 | 13.57 Million USD | -96.91% |
| 2018 | 438.93 Million USD | 1.0% |
| 2017 | 434.58 Million USD | 0.09% |
| 2016 | 434.18 Million USD | -0.35% |
| 2015 | 435.7 Million USD | -0.0% |
| 2014 | 435.71 Million USD | 0.02% |
| 2013 | 435.61 Million USD | -40.52% |
| 2012 | 732.41 Million USD | 0.1% |
| 2011 | 731.69 Million USD | 0.08% |
| 2010 | 731.1 Million USD | -0.92% |
| 2009 | 737.91 Million USD | 65.46% |
| 2008 | 445.97 Million USD | 0.94% |
| 2007 | 441.8 Million USD | 3.8% |
| 2006 | 425.62 Million USD | -0.01% |
| 2005 | 425.68 Million USD | -0.07% |
| 2004 | 425.97 Million USD | 88.62% |
| 2003 | 225.83 Million USD | 113.52% |
| 2002 | 105.76 Million USD | -43.87% |
| 2001 | 188.42 Million USD | -7.35% |
| 2000 | 203.36 Million USD | -14.98% |
| 1999 | 239.2 Million USD | 465.48% |
| 1998 | 42.3 Million USD | 8.46% |
| 1997 | 39 Million USD | 482.09% |
| 1996 | 6.7 Million USD | -67.94% |
| 1995 | 20.9 Million USD | -20.53% |
| 1994 | 26.3 Million USD | -44.98% |
| 1993 | 47.8 Million USD | -17.44% |
| 1992 | 57.9 Million USD | -10.79% |
| 1991 | 64.9 Million USD | 51.99% |
| 1990 | 42.7 Million USD | 22.0% |
| 1989 | 35 Million USD | -4.63% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 1.19 Billion USD | 0.04% |
| 2024 Q3 | 1.2 Billion USD | 0.82% |
| 2024 Q1 | 1.18 Billion USD | 0.04% |
| 2023 Q1 | 1.19 Billion USD | 0.02% |
| 2023 Q4 | 1.18 Billion USD | -0.77% |
| 2023 FY | 1.18 Billion USD | -0.69% |
| 2023 Q3 | 1.19 Billion USD | 0.03% |
| 2023 Q2 | 1.19 Billion USD | 0.03% |
| 2022 Q4 | 1.19 Billion USD | 0.04% |
| 2022 Q3 | 1.19 Billion USD | 0.03% |
| 2022 Q2 | 1.19 Billion USD | 0.02% |
| 2022 Q1 | 1.19 Billion USD | 11282.34% |
| 2022 FY | 1.19 Billion USD | 11291.63% |
| 2021 Q4 | 10.51 Million USD | -1.23% |
| 2021 FY | 10.51 Million USD | -14.23% |
| 2021 Q3 | 10.64 Million USD | -1.24% |
| 2021 Q2 | 10.77 Million USD | -1.12% |
| 2021 Q1 | 10.9 Million USD | -11.07% |
| 2020 FY | 12.25 Million USD | -9.73% |
| 2020 Q1 | 12.2 Million USD | -10.12% |
| 2020 Q2 | 12.23 Million USD | 0.23% |
| 2020 Q3 | 12.24 Million USD | 0.07% |
| 2020 Q4 | 12.25 Million USD | 0.14% |
| 2019 Q3 | 437.8 Million USD | 0.03% |
| 2019 Q4 | 13.57 Million USD | -96.9% |
| 2019 Q2 | 437.68 Million USD | 0.02% |
| 2019 FY | 13.57 Million USD | -96.91% |
| 2019 Q1 | 437.6 Million USD | -0.3% |
| 2018 FY | 438.93 Million USD | 1.0% |
| 2018 Q4 | 438.93 Million USD | 0.03% |
| 2018 Q3 | 438.8 Million USD | 0.01% |
| 2018 Q2 | 438.77 Million USD | 0.94% |
| 2018 Q1 | 434.67 Million USD | 0.02% |
| 2017 FY | 434.58 Million USD | 0.09% |
| 2017 Q4 | 434.58 Million USD | 0.02% |
| 2017 Q3 | 434.47 Million USD | 0.02% |
| 2017 Q2 | 434.38 Million USD | 0.02% |
| 2017 Q1 | 434.28 Million USD | 0.02% |
| 2016 FY | 434.18 Million USD | -0.35% |
| 2016 Q3 | 434.13 Million USD | 0.02% |
| 2016 Q4 | 434.18 Million USD | 0.01% |
| 2016 Q2 | 434.05 Million USD | 0.02% |
| 2016 Q1 | 433.98 Million USD | -0.4% |
| 2015 Q2 | 435.66 Million USD | -0.0% |
| 2015 Q3 | 435.72 Million USD | 0.02% |
| 2015 FY | 435.7 Million USD | -0.0% |
| 2015 Q1 | 435.66 Million USD | -0.01% |
| 2015 Q4 | 435.7 Million USD | -0.0% |
| 2014 Q1 | 435.61 Million USD | -0.0% |
| 2014 Q3 | 435.73 Million USD | 0.03% |
| 2014 Q2 | 435.6 Million USD | -0.0% |
| 2014 FY | 435.71 Million USD | 0.02% |
| 2014 Q4 | 435.71 Million USD | -0.01% |
| 2013 Q2 | 732.8 Million USD | 0.03% |
| 2013 Q4 | 435.61 Million USD | 0.02% |
| 2013 Q3 | 435.54 Million USD | -40.56% |
| 2013 Q1 | 732.58 Million USD | 0.02% |
| 2013 FY | 435.61 Million USD | -40.52% |
| 2012 FY | 732.41 Million USD | 0.1% |
| 2012 Q1 | 731.89 Million USD | 0.03% |
| 2012 Q2 | 732.05 Million USD | 0.02% |
| 2012 Q3 | 732.23 Million USD | 0.02% |
| 2012 Q4 | 732.41 Million USD | 0.02% |
| 2011 Q1 | 731.21 Million USD | 0.02% |
| 2011 Q2 | 731.33 Million USD | 0.02% |
| 2011 Q3 | 731.59 Million USD | 0.04% |
| 2011 Q4 | 731.69 Million USD | 0.01% |
| 2011 FY | 731.69 Million USD | 0.08% |
| 2010 Q1 | 738.66 Million USD | 0.1% |
| 2010 FY | 731.1 Million USD | -0.92% |
| 2010 Q4 | 731.1 Million USD | -0.34% |
| 2010 Q3 | 733.57 Million USD | -0.1% |
| 2010 Q2 | 734.33 Million USD | -0.59% |
| 2009 Q2 | 738.45 Million USD | 66.24% |
| 2009 FY | 737.91 Million USD | 65.46% |
| 2009 Q1 | 444.2 Million USD | -0.4% |
| 2009 Q4 | 737.91 Million USD | -0.1% |
| 2009 Q3 | 738.68 Million USD | 0.03% |
| 2008 Q4 | 445.97 Million USD | -0.09% |
| 2008 Q2 | 440.68 Million USD | -0.4% |
| 2008 Q1 | 442.44 Million USD | 0.15% |
| 2008 FY | 445.97 Million USD | 0.94% |
| 2008 Q3 | 446.37 Million USD | 1.29% |
| 2007 Q3 | 426.14 Million USD | -0.01% |
| 2007 Q4 | 441.8 Million USD | 3.68% |
| 2007 Q1 | 425.5 Million USD | -0.03% |
| 2007 FY | 441.8 Million USD | 3.8% |
| 2007 Q2 | 426.16 Million USD | 0.16% |
| 2006 Q1 | 425.97 Million USD | 0.07% |
| 2006 FY | 425.62 Million USD | -0.01% |
| 2006 Q2 | 425.87 Million USD | -0.02% |
| 2006 Q3 | 425.75 Million USD | -0.03% |
| 2006 Q4 | 425.62 Million USD | -0.03% |
| 2005 Q2 | 425.86 Million USD | 0.01% |
| 2005 Q3 | 425.81 Million USD | -0.01% |
| 2005 Q4 | 425.68 Million USD | -0.03% |
| 2005 FY | 425.68 Million USD | -0.07% |
| 2005 Q1 | 425.8 Million USD | -0.04% |
| 2004 Q2 | 226.09 Million USD | -0.03% |
| 2004 Q4 | 425.97 Million USD | 88.48% |
| 2004 FY | 425.97 Million USD | 88.62% |
| 2004 Q1 | 226.17 Million USD | 0.15% |
| 2004 Q3 | 226 Million USD | -0.04% |
| 2003 Q3 | 225.19 Million USD | 127.61% |
| 2003 FY | 225.83 Million USD | 113.52% |
| 2003 Q1 | 98.86 Million USD | -6.53% |
| 2003 Q2 | 98.94 Million USD | 0.08% |
| 2003 Q4 | 225.83 Million USD | 0.28% |
| 2002 FY | 105.76 Million USD | -43.87% |
| 2002 Q3 | 139.12 Million USD | -6.89% |
| 2002 Q4 | 105.76 Million USD | -23.98% |
| 2002 Q1 | 174.34 Million USD | -7.47% |
| 2002 Q2 | 149.41 Million USD | -14.3% |
| 2001 FY | 188.42 Million USD | -7.35% |
| 2001 Q4 | 188.42 Million USD | -1.49% |
| 2001 Q3 | 191.28 Million USD | -1.76% |
| 2001 Q2 | 194.71 Million USD | -4.03% |
| 2001 Q1 | 202.9 Million USD | -0.23% |
| 2000 Q3 | 211.63 Million USD | -12.89% |
| 2000 Q4 | 203.36 Million USD | -3.91% |
| 2000 FY | 203.36 Million USD | -14.98% |
| 2000 Q1 | 258.06 Million USD | 7.89% |
| 2000 Q2 | 242.93 Million USD | -5.86% |
| 1999 Q1 | 45.3 Million USD | 7.09% |
| 1999 Q3 | 35.4 Million USD | -16.11% |
| 1999 Q4 | 239.2 Million USD | 575.71% |
| 1999 Q2 | 42.2 Million USD | -6.84% |
| 1999 FY | 239.2 Million USD | 465.48% |
| 1998 Q2 | 47.8 Million USD | 6.46% |
| 1998 Q4 | 42.3 Million USD | 9.3% |
| 1998 FY | 42.3 Million USD | 8.46% |
| 1998 Q1 | 44.9 Million USD | 15.13% |
| 1998 Q3 | 38.7 Million USD | -19.04% |
| 1997 Q4 | 39 Million USD | 729.79% |
| 1997 Q1 | 4.6 Million USD | -31.34% |
| 1997 Q2 | 2.1 Million USD | -54.35% |
| 1997 Q3 | 4.7 Million USD | 123.81% |
| 1997 FY | 39 Million USD | 482.09% |
| 1996 Q1 | 21 Million USD | 0.48% |
| 1996 Q2 | 17 Million USD | -19.05% |
| 1996 Q3 | 16.9 Million USD | -0.59% |
| 1996 Q4 | 6.7 Million USD | -60.36% |
| 1996 FY | 6.7 Million USD | -67.94% |
| 1995 FY | 20.9 Million USD | -20.53% |
| 1995 Q1 | 25.4 Million USD | -3.42% |
| 1995 Q2 | 23.6 Million USD | -7.09% |
| 1995 Q3 | 25.7 Million USD | 8.9% |
| 1995 Q4 | 20.9 Million USD | -18.68% |
| 1994 Q2 | 37.8 Million USD | -15.63% |
| 1994 Q4 | 26.3 Million USD | -17.03% |
| 1994 FY | 26.3 Million USD | -44.98% |
| 1994 Q1 | 44.8 Million USD | -6.28% |
| 1994 Q3 | 31.7 Million USD | -16.14% |
| 1993 Q1 | 62.5 Million USD | 7.94% |
| 1993 Q2 | 35.2 Million USD | -43.68% |
| 1993 Q3 | 33 Million USD | -6.25% |
| 1993 Q4 | 47.8 Million USD | 44.85% |
| 1993 FY | 47.8 Million USD | -17.44% |
| 1992 Q4 | 57.9 Million USD | 11.99% |
| 1992 FY | 57.9 Million USD | -10.79% |
| 1992 Q1 | 65 Million USD | 0.15% |
| 1992 Q2 | 54.3 Million USD | -16.46% |
| 1992 Q3 | 51.7 Million USD | -4.79% |
| 1991 Q4 | 64.9 Million USD | 12.87% |
| 1991 Q1 | 44.3 Million USD | 3.75% |
| 1991 Q2 | 45.3 Million USD | 2.26% |
| 1991 Q3 | 57.5 Million USD | 26.93% |
| 1991 FY | 64.9 Million USD | 51.99% |
| 1990 FY | 42.7 Million USD | 22.0% |
| 1990 Q2 | 36 Million USD | -0.28% |
| 1990 Q3 | 41.5 Million USD | 15.28% |
| 1990 Q4 | 42.7 Million USD | 2.89% |
| 1990 Q1 | 36.1 Million USD | 3.14% |
| 1989 FY | 35 Million USD | -4.63% |
| 1989 Q4 | 35 Million USD | -3.85% |
| 1989 Q3 | 36.4 Million USD | -5.45% |
| 1989 Q2 | 38.5 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Abbott Laboratories | 13.59 Billion USD | 91.253% |
| Allurion Technologies Inc. | 2.3 Million USD | -51480.746% |
| Artivion, Inc. | 305.53 Million USD | -289.306% |
| Avanos Medical, Inc. | 159.4 Million USD | -646.206% |
| Butterfly Network, Inc. | 22.83 Million USD | -5108.899% |
| Butterfly Network, Inc. | 22.83 Million USD | -5108.899% |
| Boston Scientific Corporation | 8.96 Billion USD | 86.726% |
| CONMED Corporation | 971.48 Million USD | -22.437% |
| Edwards Lifesciences Corporation | 670 Million USD | -77.53% |
| Paragon 28, Inc. | 109.79 Million USD | -983.299% |
| Glaukos Corporation | 383.73 Million USD | -209.965% |
| Globus Medical, Inc. | 417.4 Million USD | -184.967% |
| Inspire Medical Systems, Inc. | 24.84 Million USD | -4687.298% |
| Integer Holdings Corporation | 959.92 Million USD | -23.911% |
| Medtronic plc | 23.87 Billion USD | 95.018% |
| Myomo, Inc. | 115.16 Thousand USD | -1032769.052% |
| Nevro Corp. | 211.47 Million USD | -462.466% |
| Owlet, Inc. | 22 Thousand USD | -5406500.0% |
| Penumbra, Inc. | 220.9 Million USD | -438.435% |
| Vicarious Surgical Inc. | 13.78 Million USD | -8528.596% |
| Smith & Nephew plc | 2.17 Billion USD | 45.313% |
| Sonendo, Inc. | 14.03 Million USD | -8374.898% |
| STERIS plc | 3.12 Billion USD | 61.879% |
| Stryker Corporation | 10.9 Billion USD | 89.089% |
| Vapotherm, Inc. | 109.97 Million USD | -981.536% |
| Zimmer Biomet Holdings, Inc. | 4.86 Billion USD | 75.565% |